Abstract
In situ injectable natural polymer-based hydrogels can be utilized to fill irregular defects and promote tissue regeneration. However, most hydrogels showed limited ability for self-biomineralization and can not guide the formation of new bone. Herein, according to the challenges encountered in advancing materials to clinical research, an injectable collagen-hyaluronic acid (Col-HA) hydrogel embedded with calcium sulfate nanorods (CSN) was developed via a bio-orthogonal reaction between norbornene (Nb) and tetrazine (Tz). The formulated CSN@Col-HA composite hydrogels not only have the potential to enhance cell adhesion and proliferation, but also serve as the system to control Ca2+ release. This composite hydrogel displayed impressive injectability, allowing straightforward in situ injection and subsequent adaption of composite hydrogels to irregularly shaped bone defects. CSN-incorporated composite hydrogels facilitate self-biomineralization, thereby fast-forming bone-like hydroxyapatite (HAp) within the hydrogel. Furthermore, Ca2+ released in a steady and sustained way from the composite hydrogels stimulated the differentiation of preosteoblasts, and promoted in situ bone growth. Our findings suggested that CSN@Col-HA composite hydrogels can successfully mediate the optimized CSN degradation, effectively accelerate HAp formation, and boost in situ bone development via the minimally invasive application.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.